An Open Label, Single Arm Study to Evaluate JWCAR201 Treating B Cell Driven Hematology Malignancy and Autoimmune Diseases
Latest Information Update: 29 Aug 2024
At a glance
- Drugs JWCAR 201 (Primary)
- Indications Autoimmune disorders; B-cell lymphoma; Systemic lupus erythematosus
- Focus Adverse reactions
Most Recent Events
- 29 Aug 2024 New trial record